B. Friedenson

发表

Many Breast Cancer Mutations Parallel Mutations in Known Viral Cancers

B. Friedenson, 2014 .

Oral contraceptives and the risk of breast cancer.

B. Friedenson, 2002, The New England journal of medicine.

A common environmental carcinogen unduly affects carriers of cancer mutations: carriers of genetic mutations in a specific protective response are more susceptible to an environmental carcinogen.

B. Friedenson, 2011, Medical hypotheses.

Inflammatory processes inordinately increase tissue specific cancer risks in carriers of mutations in BRCA1, BRCA2, ATM or Fanconi anemia genes

B. Friedenson, 2010 .

Mutations in Breast Cancer Exome Sequences Predict Susceptibility to Infections and Converge on the Same Signaling Pathways

B. Friedenson, 2015 .

Re: BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer.

B. Friedenson, 2004, Journal of the National Cancer Institute.

Inflammation targets specific organs for cancer in carriers of BRCA1/2 pathway mutations

B. Friedenson, 2010 .

Evidence That BRCA1- or BRCA2-Associated Cancers Are Not Inevitable

B. Friedenson, B. Levin, Denise Lech, 2012, Molecular medicine.

Mutations in pathways depending on BRCA1 and BRCA2 may increase cancer risks from an environmental carcinogen

B. Friedenson, 2011, Nature Precedings.

Inherited mutations impair responses to environmental carcinogens : Cancer prevention in mutation carriers

B. Friedenson, 2011 .

Partial amino-acid sequences of human and rabbit C-reactive proteins: homology with immunoglobulins and histocompatibility antigens.

B. Friedenson, A. Osmand, H. Gerwurz, 1977, Proceedings of the National Academy of Sciences of the United States of America.

A Genome Model Linking Birth Defects to Infections

B. Friedenson, 2019, bioRxiv.

A Genome Model to Explain Major Features of Neurodevelopmental Disorders in Newborns

B. Friedenson, 2019, Biomedical informatics insights.

Parental infections disrupt clustered genes encoding related functions required for nervous system development in newborns

B. Friedenson, 2018, bioRxiv.

A Genome Model to Explain Major Features of Neurodevelopmental Disorders in Newborns

B. Friedenson, 2019, Biomedical informatics insights.

Evidence that ficin is a glycoprotein.

B. Friedenson, I. Liener, 1974, Biochimica et biophysica acta.

Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

H. Gewurz, B. Friedenson, E. Shelton, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Highly active amino-terminal sialoglycopenta-, hexa- and heptapeptides from human erythrocyte NM antigens

B. Friedenson, G. Springer, H. Yang, 1980, Naturwissenschaften.

BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.

B. Friedenson, 2005, MedGenMed : Medscape general medicine.

A theory for the tissue specificity of BRCA1/2 related and other hereditary cancers

B. Friedenson, 2010 .

A theory that explains the tissue specificity of BRCA1/2 related and other hereditary cancers

B. Friedenson, 2010 .

In BRCA1 and BRCA2 breast cancers, chromosome breaks occur near herpes tumor virus sequences

B. Friedenson, 2021, bioRxiv.

Serologic and structural comparisons of rabbit IgA allotypes.

B. E. Peterson, T. Malek, B. Friedenson, 1978, Advances in experimental medicine and biology.

Partial sequence of the variable region of an anti-p-azobenzoate antibody light chain: a one solvent sequenator program.

B. Friedenson, L. Wang, J. Hora, 1976, Biochemistry.

Immunoglobulin G antibodies from an individual rabbit in which several heavy chain variants are paired with one light chain sequence.

E. Appella, B. Friedenson, D. Pressman, 1973, The Journal of biological chemistry.

The amino-acid compositions of CNBr fragment C1 from antihapten antibodies. Use of guanidine for reproducible isolation of the C1 fragment.

B. Friedenson, D. Pressman, O. Roholt, 1972, European journal of biochemistry.

Chromosome breaks in breast cancers occur near herpes tumor virus sequences and explain why the cancer comes back

B. Friedenson, 2021, bioRxiv.

The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers

B. Friedenson, Bernard Friedenson, 2007, BMC Cancer.

A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision.

B. Friedenson, 2001, MedGenMed : Medscape general medicine.

Comment on ‘The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study'

B. Friedenson, 2016, British Journal of Cancer.

Mutations in components of antiviral or microbial defense as a basis for breast cancer

B. Friedenson, 2013, Functional & Integrative Genomics.

Changes in intracellular glutathione levels in stimulated and unstimulated lymphocytes in the presence of 2-mercaptoethanol or cysteine.

B. Friedenson, J. Zmuda, 1983, Journal of immunology.

Loss of an individual idiotype on chemical modification. A strategy for assigning idiotypic determinants

B. Friedenson, B. Clevinger, J. Dickerman, 1981, The Journal of experimental medicine.

Preventing hereditary cancers caused by opportunistic carcinogens

B. Friedenson, 2011 .

The BRCA1/2 Pathway Prevents Some Leukemias and Lymphomas in Addition to Breast/Ovarian Cancers: Malignancies that Overcome Checkpoint Controls

B. Friedenson, 2010 .

Location of light chain tyrosine peptides from the combining site of a rabbit anti‐p‐azobenzoate antibody

E. Appella, B. Friedenson, D. Pressman, 1976, European journal of immunology.

Ovarian cancer, oral contraceptives, and BRCA mutations.

B. Friedenson, 2001, The New England journal of medicine.

Assignment of a tyrosyl residue from the site of a rabbit anti‐p‐azophenyl‐trimethylammonium antibody to position 102 of the heavy chain

B. Friedenson, D. Pressman, O. Roholt, 1973, European journal of immunology.

Roads to breast cancer.

B. Friedenson, 2001, The New England journal of medicine.

Breast-cancer genomics.

B. Friedenson, 2003, The New England journal of medicine.

Alcohol, acetaldehyde and breast cancer risk.

B. Friedenson, 2012, Breast.

Assessing and managing breast cancer risk: clinical tools for advising patients.

B. Friedenson, 2004, MedGenMed : Medscape general medicine.

Localization within the heavy chain sequence of tyrosyl peptides from the combining sites in a rabbit anti-3-azopyridine antibody preparation.

E. Appella, B. Friedenson, D. Pressman, 1972, Biochemical and biophysical research communications.

Peptides from the site of rabbit antibody: anti-3-azopyridine antibody.

B. Friedenson, D. Pressman, O. Roholt, 1971, Journal of immunology.

A possible difference in the heterogeneity of the heavy and light chains from a rabbit anti-p-azobenzoate antibody preparation.

B. Friedenson, K. Grzyb, L. Wang, 1977, Journal of immunology.

A simple general method of exactly comparing different binding activities and antigenic properties of antibodies by obtaining duplicate copies from a single isoelectric focusing gel.

B. Friedenson, C. Soong, 1984, Journal of immunological methods.

The active site sequence of multiple forms of ficin.

B. Friedenson, I. Liener, 1972, Archives of biochemistry and biophysics.

A Genome Model to Explain Major Features of Neurodevelopmental Disorders

B. Friedenson, 2018 .

Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives.

B. Friedenson, Harvey Friedenson, 2002, MedGenMed : Medscape general medicine.

Is mammography indicated for women with defective BRCA genes? Implications of recent scientific advances for the diagnosis, treatment, and prevention of hereditary breast cancer.

B. Friedenson, B Friedenson, 2000, MedGenMed : Medscape general medicine.